Generation of vascularized brain organoids to study neurovascular interactions

Xin-Yao Sun, Xiang-Chun Ju, Yang Li, Peng-Ming Zeng, Jian Wu, Yingying Zhou, Libing Shen, Jian Dong, Yuejun Chen, Zhen‐Ge LuoeLife 2022 · DOI

TL;DR

Researchers have developed a novel method to create vascularized human brain organoids by fusing separate brain and blood vessel organoids. These "fused organoids" exhibit functional blood-brain barrier-like structures and integrated microglia, offering a more complete model for studying brain development, diseases, and drug interactions.

What Problem Does This Paper Address?

Brain organoids are powerful tools for studying brain development and diseases, but they lack a crucial component of the real brain: a vascular system. Blood vessels are essential for supplying oxygen and nutrients, regulating neurogenesis, and forming the blood-brain barrier (BBB) that protects the brain. Without this vascular network, current brain organoids have limited utility for modeling many aspects of brain function and disease. This paper addresses this limitation by creating brain organoids that are successfully vascularized.

Methods

The authors developed a two-pronged approach:

  1. Vessel Organoid (VOr) Generation: They started with human embryonic stem cells (hESCs) and guided their differentiation into vascular progenitors (VPs) and then endothelial cells (ECs). These ECs were cultured to form self-organizing vessel organoids with integrated vascular structures, including ECs and pericytes.
  2. Brain Organoid (BOr) Generation: Standard protocols were used to generate brain organoids from hESCs, focusing on neural progenitor development.
  3. Fusion Strategy: Crucially, they then fused the VOrs and BOrs together within a Matrigel droplet. This co-culture approach allowed the vessels to invade and integrate with the brain organoid.

They employed several techniques to characterize these organoids:

  • Quantitative PCR (qPCR): To assess gene expression of stemness and vascular markers.
  • Flow Cytometry: To quantify specific cell populations, like ECs.
  • Immunostaining: To visualize and confirm the presence and localization of various cell types (neurons, endothelial cells, pericytes, microglia) and structures (tight junctions, BBB components).
  • Single-cell RNA Sequencing (scRNA-seq): To comprehensively analyze the cell composition and identify different cell types within the VOrs, comparing them to in vivo brain vasculature.
  • Functional Assays:
    • Fluid Injection: To demonstrate the patency and integrity of the vascular network.
  • Dil-Ac-LDL Uptake: To assess the functional capacity of ECs.
  • BBB Permeability Assay: Using fluorescently labeled peptides (Angiopep-2) to test the selective permeability of the BBB-like structures.
  • Electrophysiology: To measure neuronal activity (sEPSC frequency and amplitude) in BOrs vs. fVBOrs.
  • Immune Challenge: Treating organoids with LPS to assess microglial response.

Datasets

  • Newly Generated Data: The study generated transcriptomic data from their vessel organoids (VOrs) at day 40, which has been deposited in the NCBI Sequence Read Archive (SRA) under accession number SRP338043.
  • Publicly Available Datasets:
    • Mouse brain vascular scRNA-seq data (He et al., 2018; Vanlandewijck et al., 2018) (GEO: GSE98816).
  • Human neocortical scRNA-seq data (Polioudakis et al., 2019) (dbGaP: phs001836).

Key Insights and Ideas

  • Vascularization is Key: The absence of vasculature is a major bottleneck in current brain organoid models. This work demonstrates a viable strategy to overcome this.
  • Fusion is More Than Just Co-culture: Simply co-culturing brain and vessel cells doesn't achieve the same level of integration. The fusion approach allows for robust vascular invasion and BBB formation.
  • Brain Organoids Benefit from Vessels: The fused organoids showed increased neural progenitor proliferation and reduced apoptosis, suggesting that the vascular niche actively supports neural development and survival.
  • Functional BBB and Microglia: The fVBOrs not only developed BBB-like structures with selective permeability but also incorporated functional microglia that responded to immune stimuli and engaged in synaptic pruning.
  • A More Complete Model: These fVBOrs represent a significant step towards creating more physiologically relevant in vitro models for studying complex neurovascular interactions, immune responses, and drug delivery to the brain.

Key Results

  • Successful Vascular Integration: Fused brain organoids (fVBOrs) exhibited robust, integrated vascular networks that were patent and capable of fluid flow.
  • Blood-Brain Barrier Formation: fVBOrs displayed functional BBB-like structures, evidenced by the expression of tight junction proteins (Claudin5, ZO-1) and selective permeability to Angiopep-2.
  • Enhanced Neurogenesis: fVBOrs showed increased neuroepithelium thickness and a higher density of neural progenitors (PAX6+, p-VIM+) compared to BOrs alone.
  • Reduced Apoptosis: The central regions of fVBOrs had significantly fewer apoptotic cells than BOrs, indicating improved survival, likely due to vascular support.
  • Functional Microglia: Microglia integrated into fVBOrs responded to LPS stimulation and demonstrated synaptic engulfment, as shown by PSD95 puncta within IBA1+ cells.
  • Improved Neuronal Excitability: Neurons in fVBOrs showed decreased sEPSC frequency but increased amplitude, suggesting accelerated functional maturation.

Limitations and Future Work

  • Lack of Active Blood Flow: The current fVBOr model does not have active blood flow. The authors suggest combining microfluidic techniques ("organ-on-a-chip") or in vivo grafting as future directions to achieve this.
  • Limited Maturation Time: The study mentions refining the model to allow for longer growth times in the lab.
  • Microglia Identity Factors: While microglia were successfully integrated and functional, the specific factors driving their identity and migration into the BOr remain unclear and warrant further investigation.
  • Astrocytes and Neurovascular Units: The role of astrocytes in the neurovascular unit and BBB maturation needs further exploration.
  • Immune Surveillance: The involvement of microglia in immune surveillance within the fVBOrs is an area for future study.

Summary updated

Abstract

Brain organoids have been used to recapitulate the processes of brain development and related diseases. However, the lack of vasculatures, which regulate neurogenesis and brain disorders, limits the utility of brain organoids. In this study, we induced vessel and brain organoids, respectively, and then fused two types of organoids together to obtain vascularized brain organoids. The fused brain organoids were engrafted with robust vascular network-like structures and exhibited increased number of neural progenitors, in line with the possibility that vessels regulate neural development. Fusion organoids also contained functional blood-brain barrier-like structures, as well as microglial cells, a specific population of immune cells in the brain. The incorporated microglia responded actively to immune stimuli to the fused brain organoids and showed ability of engulfing synapses. Thus, the fusion organoids established in this study allow modeling interactions between the neuronal and non-neuronal components in vitro, particularly the vasculature and microglia niche.
BibTeX
@inproceedings{sun2022generation,
  author = {Xin-Yao Sun and Xiang-Chun Ju and Yang Li and Peng-Ming Zeng and Jian Wu and Yingying Zhou and Libing Shen and Jian Dong and Yuejun Chen and Zhen‐Ge Luo},
  title = {{Generation of vascularized brain organoids to study neurovascular interactions}},
  booktitle = {eLife},
  year = {2022},
  doi = {10.7554/elife.76707},
}
Figure